Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded ...
Dell Laser Consultants is proud to be among the first practices in the United States to offer the TECNIS PureSee™ intraocular lens (IOL), the newest extended depth of focus (EDOF) lens from Johnson & ...
With best-in-class image contrast and low-light performance, TECNIS Odyssey IOL expands the Johnson & Johnson portfolio of ...
The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...
Complex cataract surgery presents unique challenges when capsular support is absent or compromised by trauma, ...
ReportsnReports.com adds the global intraocular lens (IOL) market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly ...
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know about a common procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results